About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Translational Lung Cancer Research
›
Top Articles
Translational Lung Cancer Research
Oncology
4.4
(top 3%)
Impact Factor
4.8
(top 3%)
extended IF
49
(top 8%)
H-Index
479
authors
1.3K
papers
15K
citations
1.4K
citing journals
8K
citing authors
Most Cited Articles of Translational Lung Cancer Research
Title
Year
Citations
Non-small cell lung cancer: current treatment and future advances
2016
762
Targeted therapy for non-small cell lung cancer: current standards and the promise of the future
2015
389
The epidemiology of lung cancer
2018
299
Global trends of lung cancer mortality and smoking prevalence
2015
240
Immune checkpoint inhibitors in clinical practice: update on management of immune-related toxicities
2015
238
Known and putative mechanisms of resistance to EGFR targeted therapies in NSCLC patients with EGFR mutations-a review
2015
186
Recurrence after surgery in patients with NSCLC
2014
175
Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer
2015
135
Third-generation epidermal growth factor receptor-tyrosine kinase inhibitors in T790M-positive non-small cell lung cancer: review on emerged mechanisms of resistance
2016
110
Current state of immunotherapy for non-small cell lung cancer
2017
107
Methods of measurement for tumor mutational burden in tumor tissue
2018
106
Epigenetics in non-small cell lung cancer: from basics to therapeutics
2016
94
Phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin (PI3K-Akt-mTOR) signaling pathway in non-small cell lung cancer
2015
92
Radiomics of pulmonary nodules and lung cancer
2017
91
Implementing tumor mutational burden (TMB) analysis in routine diagnostics-a primer for molecular pathologists and clinicians
2018
91
Current standards for clinical management of small cell lung cancer
2018
89
Small cell lung cancer tumors and preclinical models display heterogeneity of neuroendocrine phenotypes
2018
88
Comparison of methods for circulating cell-free DNA isolation using blood from cancer patients: impact on biomarker testing
2016
87
Treatment for small cell lung cancer, where are we now?-a review
2016
82
Rebuttal from Dr. Nguyen and Dr. Palma
2016
78
Next generation sequencing techniques in liquid biopsy: focus on non-small cell lung cancer patients
2016
75
Classification of pulmonary neuroendocrine tumors: new insights
2017
72
Lung cancer molecular epidemiology in China: recent trends
2014
72
Small cell lung cancer (SCLC): no treatment advances in recent years
2016
72
Cancer stem cells and immunoresistance: clinical implications and solutions
2015
69
previous
2013
2014
2015
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.